Trails Edge Biotechnology Offshore Fund, LP — Form D/A
Trails Edge Biotechnology Offshore Fund, LP of ATLANTA, GA, a pooled investment fund, filed a Form D amendment with the SEC on 2026-06-25. $292.9M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2026-06-25
- Form: D/A
- Accession: 0001493152-26-030079
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Amount sold: $292.9M
- Investors: 36
- Security types: fund interests
- SEC file number: 021-549855
Issuer
- Name: Trails Edge Biotechnology Offshore Fund, LP
- CIK: 0002070384
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2025
- Address: 3445 PEACHTREE ROAD NE SUITE 900, ATLANTA, GA, 30326
- Phone: 770-600-9010
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Matthew Diaz | Related Person | Atlanta, GA |
| Ortav Yehudai | Related Person | Atlanta, GA |
| Ortav Yehudai | Executive Officer | Atlanta, GA |
| Matthew Diaz | Executive Officer | Atlanta, GA |
| - Trails Edge Capital Partners, LP | Executive Officer | Atlanta, GA |
| - Trails Edge Biotechnology Fund GP, LP | Executive Officer | Atlanta, GA |
Other filings by this issuer (1)
More